Interested in Artist Trial Gastric Cancer Jco? On this page, we have collected links for you, where you will receive the most necessary information about Artist Trial Gastric Cancer Jco.
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.4001
DOI: 10.1200/JCO.2019.37.15_suppl.4001 Journal of Clinical Oncology - published online before print May 26, 2019 ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC).Cited by: 24
https://ascopubs.org/doi/full/10.1200/jco.2011.39.1953
Dec 19, 2011 · The ARTIST (Adjuvant Chemoradiation Therapy in Stomach Cancer) trial was the first study to our knowledge to investigate the role of postoperative chemoradiotherapy therapy in patients with curatively resected gastric cancer with D2 lymph node dissection.Cited by: 442
https://ascopubs.org/doi/abs/10.1200/JCO.2014.58.3930
Jan 05, 2015 · The Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) trial tested whether the addition of radiotherapy to adjuvant chemotherapy improved disease-free survival (DFS) in patients with D2-resected gastric cancer (GC).Cited by: 293
https://pubmed.ncbi.nlm.nih.gov/25559811/
The Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) trial tested whether the addition of radiotherapy to adjuvant chemotherapy improved disease-free survival (DFS) in patients with D2-resected gastric cancer (GC).Cited by: 293
https://ascopubs.org/doi/full/10.1200/JCO.2014.59.1941
This was the unique feature of the ARTIST trial, which randomly assigned only patients who underwent a D2 resection for pathologically staged IB to IV (M0) gastric cancer to adjuvant chemotherapy involving six cycles of capecitabine and cisplatin (XP) or 2 cycles of XP before and after concurrent capecitabine and radiotherapy (XPRT).Cited by: 8
https://www.researchgate.net/publication/333417640_ARTIST_2_Interim_results_of_a_phase_III_trial_involving_adjuvant_chemotherapy_andor_chemoradiotherapy_after_D2-gastrectomy_in_stage_IIIII_gastric_cancer_GC
Journal of Clinical Oncology ... subset analysis indicated the potential benefit of adjuvant chemoradiotherapy in node-positive locally advanced gastric cancer [41], and the ARTIST 2 trial was ...
https://ascopubs.org/doi/abs/10.1200/jco.2015.33.3_suppl.tps228
Jan 20, 2015 · DOI: 10.1200/jco.2015.33.3_suppl.tps228 Journal of Clinical Oncology - published online before print January 20, 2015 Multicenter phase III trial of adjuvant chemoradiotherapy in stomach tumors 2 (ARTIST 2).Cited by: 4
https://pubmed.ncbi.nlm.nih.gov/33278599/
Background: Adjuvant chemotherapy and chemoradiotherapy are some of the standards of care for gastric cancer (GC). The Adjuvant chemoRadioTherapy In Stomach Tumors (ARTIST) 2 trial compares two adjuvant chemotherapy regimens and chemoradiotherapy in patients with D2-resected, stage II or III, node-positive GC.
https://www.sciencedirect.com/science/article/pii/S0923753420431722
The influence of metastatic lymph node ratio on the treatment outcomes in the Adjuvant chemoRadioTherapy In Stomach Tumors (ARTIST) trial: a phase III trial. J Gastric Cancer, 16 (2016), pp. 105-110. View Record in Scopus Google Scholar. 8. ... JCO Clin Cancer Inform, 2 (2018), pp. 1-14.
https://pubmed.ncbi.nlm.nih.gov/17075117/
Purpose: In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorouracil (DCF) over docetaxel and cisplatin for comparison against cisplatin and fluorouracil (CF; reference regimen) in the phase III part. Patients and methods: Advanced gastric cancer patients were randomly assigned to ...
We hope you have found all the information you need about Artist Trial Gastric Cancer Jco through the links above.
